Who is sponsoring NCT04842422?

NCT04842422 is sponsored by Medical University of Graz.

What condition does NCT04842422 study?

NCT04842422 studies Actinic Keratoses.

What drugs are being tested in NCT04842422?

Interventions: Imiquimod 3.75% Cream.

What is the status of NCT04842422?

NCT04842422 is currently COMPLETED.

Last reviewed 2022-01-11 · How we verify

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

NCT04842422 PHASE4 COMPLETED

Earliest Stage Treatment of Actinic Keratosis with Imiquimod 3.75% Cream: The study is to demonstrate that Aktinic Keratosis are present before they are clinically visible, i.e. in a subclinical stage. Since on the basis of the research situation, also subclinical AK can proliferate into the dermis, it is possible that with the application of Imiquimod on chronically light-exposed skin, undetected squamous cell carcinoma can be recognized and treated at the same time.

Details

Lead sponsor	Medical University of Graz
Phase	PHASE4
Status	COMPLETED
Enrolment	48
Start date	Fri Apr 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Actinic Keratoses

Interventions

Imiquimod 3.75% Cream

Countries

Austria